leucine zipper like post translational regulator 1
Last updated 3 Apr 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The LZTR1 gene provides instructions for making a protein whose exact function is unknown. The LZTR1 protein is made in cells throughout the body. Within cells, it is found in the Golgi apparatus, which is a structure in which newly produced proteins are modified. Studies suggest that the LZTR1 protein may help stabilize this structure. Researchers suspect that this protein may also be associated with the CUL3 ubiquitin ligase complex, which is part of the cell machinery that breaks down (degrades) unneeded proteins.
Video picks for GenesVideo library
Normal function
The LZTR1 gene provides instructions for making a protein whose exact function is unknown. The LZTR1 protein is made in cells throughout the body. Within cells, it is found in the Golgi apparatus, which is a structure in which newly produced proteins are modified. Studies suggest that the LZTR1 protein may help stabilize this structure. Researchers suspect that this protein may also be associated with the CUL3 ubiquitin ligase complex, which is part of the cell machinery that breaks down (degrades) unneeded proteins.
Based on its role in several tumour types, the LZTR1 protein is thought to act as a tumour suppressor. Tumour suppressors are proteins that keep cells from growing and dividing too rapidly or in an uncontrolled way.
Conditions referring to this gene or chromosome
Other names
BTBD29
leucine-zipper-like transcriptional regulator 1
LZTR-1
NS10
SWNTS2
Patient picks for Genes

Health news
Influencers are promoting dangerous peptides on social media – and regulators are struggling to keep up
Once confined to niche bodybuilding forums and hardcore gyms, unproven injectable peptides are now being openly marketed online to the average gym-goer by social media influencers – and regulators struggling to keep up. Across Instagram, TikTok or YouTube, unapproved and harmful peptide products are being promoted as shortcuts to fat loss, anti-ageing, health and recovery and muscle growth. Peptides actually occur naturally in our body. They regulate a variety of important functions, including metabolism, appetite, hormone production and tissue repair. Synthetic versions of peptides are also used in some medicines, which are legitimate and have been clinically proven. These include GLP-1s (which are used for weight loss and managing diabetes) and insulin. But a booming, parallel “grey market” now exists online for unapproved peptide compounds. These products are primarily being sold by so-called wellness brands and in influencer-led storefronts. Many of these products are marketed as cutting-edge solutions for optimising health and body enhancement. The problem is that many of these substances have not undergone full clinical safety evaluation and are not approved for human use. Many have also been found to be contaminated with other harmful ingredients. Unapproved injectable peptides therefore pose serious health risks. Some of the risks they may pose00092-0/abstract) include nausea, vomiting, abdominal pain, gastrointestinal issues, headaches and fatigue or weakness. Immune issues, as well as allergic reactions and infections have also been reported. Moreover, there’s a clear lack of rigorous human safety data. Yet these risks often aren’t disclosed by the people selling them.
by Luke Cox

Cancer
What it's like to be diagnosed with skin cancer
With increased accessibility to exotic destinations and a rise in sunbed use, skin cancer rates are soaring. In fact, it's now the fifth most common cancer in the UK (and the second most common in young adults), killing over 2,500 people a year. We speak to Loti Jackson who was diagnosed with the disease at 27 and explore the skin cancer warning signs to look out for.
by Karen Gordon

Ear, nose and throat
When it feels like something is stuck in your throat
Some patients tell me that they would sooner have constant pain than put up with swallowing difficulties. I suppose it's because long-term pain is something the brain can 'tune out' whereas a symptom that occurs in connection with an activity such as swallowing or that comes and goes is less easy to ignore. Also, whatever the cause of pain, the supermarket shelves are stuffed with tablets to help relieve it. You can't say the same about swallowing problems.
by Dr Laurence Knott

Sexual health
What living with HIV is like today
HIV used to be seen as a terminal illness, but important medical improvements in recent decades have changed this. It's now possible for HIV-positive people to live a normal, healthy life with the right treatment.
by Léa Surugue

Allergies, blood and immune system
What it's like to have lupus
You may have heard of lupus, but if someone asked you about this poorly understood condition, would you know enough to answer? It's estimated that lupus affects approximately one in 1,000 people in the UK and 5 million people worldwide. And many more cases remain undiagnosed due to poor awareness of the condition and a lack of specialist referrals.
by Karen Gordon

Cancer
What it's like to be a breast surgeon with breast cancer
As a consultant breast surgeon, Dr Liz O'Riordan was used to performing operations, reassuring frightened women and breaking bad news. What she wasn't so familiar with was being the patient herself.
by Natalie Healey
Related patient information and medicines

Patient information leaflet
Astigmatism
Astigmatism is a common condition that can be corrected by glasses or contact lenses, or cured with laser eye surgery. What is astigmatism. Astigmatism astigmatism Astigmatism is a type of visual problem called a 'refractive error', meaning there is a problem in the eye that prevents the incoming light rays from being focused correctly. More.

Patient information leaflet
Myopia
Complete and permanent resol... Others have a significant improvement even though perfect vision is not achieved and glasses or contact lenses may still be needed. Refractive surgery must be carried out in premises registered with the Care Quality Commission (CQC) in England, or the equivalent regulator in Scotland, Wales and Northern Ireland..

Patient information leaflet
Dental implants
A dental implant is a modern way of replacing missing teeth. It takes the form of a titanium post that fixes into your jawbone and is topped by an artificial tooth. The crown of your dental implant will be almost indistinguishable from the rest of your teeth, and will work like a normal tooth - making implants a very attractive, long-term.

Patient information leaflet
Can I take Alogliptin and Rybelsus together?
Simply search for your medicines to see potential interactions and w... Disclaimer This information is for general educational purposes only and should not be relied upon as a substitute for professional medical advice. Always consult your GP, pharmacist, or another qualified healthcare professional before making decisions about your medications..

Patient information leaflet
Preventing infection after splenectomy
If you do not have a spleen. The risk is reduced by immunisation, taking regular low-dose antibiotics, and taking full-strength antibiotics as soon as the first sign of infection develops. What can I do to reduce the risk of infection after splenectomy. The following measures can be protective against infection after splenectomy. You should be.

Patient information leaflet
Pulmonary embolism
Pulmonary embolism symptoms The symptoms will depend on how large or small the clot is, and on how well the person's lungs can cope with the clot. People who are frail or have existing illness are likely to have worse symptoms than someone who is fit and well. Symptoms often start suddenly. A small PE may cause: No symptoms at all (common)..
Further reading and references
- leucine zipper like post translational regulator 1; MedlinePlus, National Library of Medicine.
- Frattini V, Trifonov V, Chan JM, Castano A, Lia M, Abate F, Keir ST, Ji AX, Zoppoli P, Niola F, Danussi C, Dolgalev I, Porrati P, Pellegatta S, Heguy A, Gupta G, Pisapia DJ, Canoll P, Bruce JN, McLendon RE, Yan H, Aldape K, Finocchiaro G, Mikkelsen T, Prive GG, Bigner DD, Lasorella A, Rabadan R, Iavarone A. The integrated landscape of driver genomic alterations in glioblastoma. Nat Genet. 2013 Oct;45(10):1141-9. doi: 10.1038/ng.2734. Epub 2013 Aug 5.
- Paganini I, Chang VY, Capone GL, Vitte J, Benelli M, Barbetti L, Sestini R, Trevisson E, Hulsebos TJ, Giovannini M, Nelson SF, Papi L. Expanding the mutational spectrum of LZTR1 in schwannomatosis. Eur J Hum Genet. 2015 Jul;23(7):963-8. doi: 10.1038/ejhg.2014.220. Epub 2014 Oct 22.
- Piotrowski A, Xie J, Liu YF, Poplawski AB, Gomes AR, Madanecki P, Fu C, Crowley MR, Crossman DK, Armstrong L, Babovic-Vuksanovic D, Bergner A, Blakeley JO, Blumenthal AL, Daniels MS, Feit H, Gardner K, Hurst S, Kobelka C, Lee C, Nagy R, Rauen KA, Slopis JM, Suwannarat P, Westman JA, Zanko A, Korf BR, Messiaen LM. Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet. 2014 Feb;46(2):182-7. doi: 10.1038/ng.2855. Epub 2013 Dec 22.
- Smith MJ, Isidor B, Beetz C, Williams SG, Bhaskar SS, Richer W, O'Sullivan J, Anderson B, Daly SB, Urquhart JE, Fryer A, Rustad CF, Mills SJ, Samii A, du Plessis D, Halliday D, Barbarot S, Bourdeaut F, Newman WG, Evans DG. Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis. Neurology. 2015 Jan 13;84(2):141-7. doi: 10.1212/WNL.0000000000001129. Epub 2014 Dec 5.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

